Refine Results
- view as grid
- view as list
Medicare’s Coverage Decision for the New Alzheimer’s Drug and Why It Matters
This policy watch discusses the implications of Medicare’s preliminary National Coverage Determination for the new Alzheimer’s drug, Aduhelm, on the 2022 Medicare Part B premium and the possibility of an adjustment based on the coverage decision. The piece also discusses the implications for Medicare spending and the connection to ongoing policy discussions around prescription drug proposals in the Build Back Better Act.
Blog Read More
How are Large Private Insurers Covering At-Home Rapid Tests?
Less than a week after a new federal mandate to cover such products took effect, about half of the nation’s largest private insurers allow enrollees to directly obtain rapid at-home COVID-19 tests from specific sources without having to pay anything upfront, a new KFF analysis finds. The new coverage requirement…
News Release Read More Key Facts on Health and Health Care by Race and Ethnicity
With the COVID-19 pandemic impacting communities of color disproportionately in their health and economic well-being, long-term racial and ethnic disparities have received growing attention. But these inequities in our health system are not new and are a part of larger issues of systemic racism. An updated KFF chart pack analyzes…
News Release Read More
Key Facts on Health and Health Care by Race and Ethnicity
This chart pack examines how people of color fare compared to White people across a broad array of measures of health coverage, access, and use; health status, outcomes, and behaviors; social determinants of health; and COVID-19 impacts to provide insight into the status of racial disparities in health and health care.
Report Read More
Health Coverage of Immigrants
This fact sheet provides an overview of health coverage for noncitizens and discusses key issues for health coverage and care for immigrant families today.
Fact Sheet Read More Ending COVID-19 Emergency Declarations Will Bring an End to Flexibilities that Aided Patients, Providers, Insurers, and Public Programs in Responding to the Pandemic
When the federal government ends COVID-19 emergency declarations that were declared in the early days of the pandemic, it will bring to a close several changes that were enacted temporarily to enable the U.S. health care system to better deal with the crisis. A new KFF resource details a number…
News Release Read More
Status of State Medicaid Expansion Decisions: Interactive Map
This page displays an interactive map of the current status of state decisions on the Affordable Care Act’s Medicaid expansion. Additional Medicaid expansion resources are listed (with links) below the map.
Issue Brief Read More
Employer Coverage of Travel Costs for Out-of-State Abortion
This Policy Watch gives an overview of employers offering to cover travel expenses for workers who need to go out of state for an abortion in the context of increasing restrictions on abortion around the country. We discuss who is offering these benefits, the implications for workers, and some of the legal and political concerns for employers.
Blog Read More
What Happens When COVID-19 Emergency Declarations End? Implications for Coverage, Costs, and Access
This brief provides an overview of the major health-related COVID-19 federal emergency declarations that have been made since early on in the pandemic, summarizes the flexibilities triggered by each, and identifies the implications for their ending, related to coverage, costs, and payment for COVID-19 testing, treatments, and vaccines; Medicaid coverage and federal match rates; telehealth; access to medical countermeasures through FDA emergency use authorization (EUA); and other Medicaid, Medicare and private health insurance flexibilities.
Issue Brief Read More